Dendritic Cell Vaccine Shows Preliminary Activity in Advanced HCC
Written by
Cancer Network
Published
0
comments
0
min
The addition of dendritic cells to TACE in patients with intermediate-stage HCC did not significantly increase the incidence or severity of AEs.